Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Trade War Showdown: What Trump’s Latest Threats Mean for Canada and the U.S.
Ari Hawkins, Trade Reporter at POLITICO, examines Canada’s retaliation, Trump’s latest trade threats and the potential impact on businesses and consumers.
Inside the Ticketing Problem Fans Can’t Ignore: Rising Prices, Resale Markups and Scarcity
Dana Lattouf, CEO of Ticketto, explores why sports tickets cost more, who is driving prices higher and how ticket marketplaces can improve fan access.
The US Open Playbook: How Brands Are Winning Over Fans
Heineken's CMO reveals the marketing playbook behind 30 years at the US Open - Serena Williams, zero-alcohol beer, and turning fans into friends
How the US Open Keeps Upping Its Tech Game
Step inside the command center running the US Open's AI for 14 million fans - discover new features like Serve Quality, Match Chat, and the tech behind it all
Apple’s Foldable iPhone Is Wild! An Expert Reveals What You Need To Know Before Buying
Mark Spoonauer, Global Editor-in-Chief of Tom’s Guide, tested the iPhone Duo and shares the surprising details Apple fans need to know.
Hershey’s Meets KATSEYE: Inside the Brand’s Gen Z Strategy
Dan Mohnshine, Hershey’s VP of Creation Strategy & Innovation, discusses the brand’s premium chocolate push and strategy to connect with younger consumers.
